Protagenic Therapeutics, Inc. (PTIX)
NASDAQ: PTIX · Real-Time Price · USD
2.110
-0.120 (-5.38%)
At close: Nov 28, 2025, 1:00 PM EST
2.030
-0.080 (-3.80%)
After-hours: Nov 28, 2025, 4:23 PM EST
Protagenic Therapeutics Statistics
Total Valuation
PTIX has a market cap or net worth of $4.12 million. The enterprise value is $5.40 million.
| Market Cap | 4.12M |
| Enterprise Value | 5.40M |
Important Dates
The last earnings date was Wednesday, November 26, 2025, after market close.
| Earnings Date | Nov 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PTIX has 1.93 million shares outstanding. The number of shares has increased by 28.54% in one year.
| Current Share Class | 1.93M |
| Shares Outstanding | 1.93M |
| Shares Change (YoY) | +28.54% |
| Shares Change (QoQ) | +18.30% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 5.48% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.38 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 2.89 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 41.41 |
| Average Volume (20 Days) | 80,102 |
Short Selling Information
The latest short interest is 56,970, so 2.94% of the outstanding shares have been sold short.
| Short Interest | 56,970 |
| Short Previous Month | 28,771 |
| Short % of Shares Out | 2.94% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | n/a |
| Pretax Income | n/a |
| Net Income | n/a |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | n/a |
| Book Value Per Share | n/a |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | -3.63M |
| FCF Per Share | -$1.87 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PTIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.54% |
| Shareholder Yield | -28.54% |
| Earnings Yield | n/a |
| FCF Yield | -87.97% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |